We are live on
!
Find out more
SMC
S. Muoio & Co Portfolio holdings
AUM
$75.7M
1-Year Est. Return
42.51%
This Fund
S&P 500
This Quarter
Est. Return
+16.77%
1 Year Est. Return
+42.51%
3 Year Est. Return
+327.42%
5 Year Est. Return
+691.71%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$15.9M
(+17%)
Cap. Flow
-$7.18M
Cap. Flow
% of AUM
-6.45%
Top 10 Holdings %
Top 10 Hldgs %
47.05%
Holding
91
New
16
Increased
10
Reduced
12
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$3.56M |
| 2 |
AGN
Allergan plc
AGN
|
+$2.16M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$2.14M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$2.02M |
| 5 |
GBL
GAMCO Investors, Inc.
GBL
|
+$1.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.92M |
| 2 |
CBM
Cambrex Corporation
CBM
|
+$2.99M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$2.84M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$2.23M |
| 5 |
MCRN
Milacron Holdings Corp.
MCRN
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 30.44% |
| 2 | Miscellaneous | 15% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 13.26% |
| 5 | Technology | 10.61% |
Similar funds
FFMBT
NVPX
WM
RA
RC
GI
PM
PIMH
S. Muoio & Co's Q4 2019 Portfolio in Review
As of Q4 2019, S. Muoio & Co held 91 positions worth $111M, up 17% from $95.3M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
S. Muoio & Co withdrew a net $7.18M in Q4 2019, closing 20 positions and reducing 12 holdings. Its most notable exit was Celgene Corp, an estimated $7.92M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 30% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, S. Muoio & Co opened a new position in Audentes Therapeutics, Inc worth $3.41M.
- S. Muoio & Co's largest Q4 2019 buy was Audentes Therapeutics, Inc: 57,000 shares worth $3.41M.
- S. Muoio & Co added most to Paramount Global Class B in Q4 2019, an estimated $3.56M increase.
- S. Muoio & Co's biggest Q4 2019 reduction was Phibro Animal Health, cutting an estimated $1.02M.
- S. Muoio & Co fully exited Celgene Corp in Q4 2019, selling an estimated $7.92M.
- S. Muoio & Co's ten largest holdings make up 47% of its $111M portfolio in Q4 2019.
- S. Muoio & Co opened 16 new positions and closed 20 in Q4 2019.
- S. Muoio & Co's portfolio value rose 17% quarter-over-quarter to $111M.
Based on S. Muoio & Co's 13F filing for Q4 2019, filed 12 Feb 2020.